A daily newsletter summarizing recent activity & interesting startups globally
RECENT NOTABLE ACTIVITY – LIFE SCIENCE – SOFTWARE
- IDbyDNA, a precision medicine company offering DNA search engine to identify pathogens for infectious disease identification has raised $9 million in Series A financing round lead by ARTIS Ventures, with additional investments from ARUP Laboratories and other private investors. Link
- Science 37, a technology-enabled clinical research company which offers mobile applications that allow patients to participate in trials and expand clinical trial access has raised $31 million Series B financing led by Redmile Group, with further funding from Series A lead investors Lux Capital and dRx Capital, as well as a strategic investment from Sanofi Genzyme BioVentures. Link
- Benchling, a biotech company which offers IT software solutions for life sciences research and collaboration has raised $7 million in growth funding round led by Thrice Capital and was joined by Andreessen Horowitz and a number of angel investors, including Y Combinator partner Geoff Ralston, Sequoia partner Matt Huang and CXO of Tencent David Wallerstein. Link
- 4G Clinical, a clinical trials software company focused on simplifying and accelerating drug development process has raised $5 million in Series A1 financing led by Schooner Capital. Link
- Lab7 Systems, a provider of workflow management solutions for life sciences has raised $3 million in Series A funding round for platform growth and commercial expansion. Link
- Complion, a developer and provider of software solutions for clinical trial regulatory documentation has raised $2.9 million in Series A funding by JumpStart from its NEXT fund. Link
- Cyclica, an in silico drug discovery company that offers a predictive analytics platform for drug discovery has raised $2.4 million in Series A1 financing round led by GreenSky through the GreenSky Accelerator Fund I, LP, with additional investment from China Canada Angel Alliance, and the family of Mr. Anthony Griffiths. Link
- Ranomics which is building a database of rare genetic variants using wet lab experimental pipeline to map all genetic variants and catalogs the functionality of each variant using data modelling and statistical analysis has raised $1.2 million in Seed funding. Link
- Immortagen which develops AI-based NGS solutions for cancer diagnostics has raised an undisclosed amount in Series A equity financing round. It previously received funding from the Iowa Economic Development Authority and the University of Iowa GAP Commercialization Fund. Link
- GQ Life Sciences (formerly GenomeQuest), a life science information and search company has been acquired by Aptean, a provider of enterprise software solutions. Link
- PierianDx, a company operating in field of clinical genomic analysis, interpretation and reporting, has acquired Tute Genomics, a genomics software company offering solutions for precision and genome guided medicine. Link
- Instem, a provider of IT solutions for healthcare market has acquired Notocord which provides software solutions for data acquisition and analysis in preclinical studies and is a recognized leader in cardiovascular, respiratory, electrophysiology and nervous system research areas. The acquisition is a part of Instem’s mission to consolidate and harmonize key application areas that are helping customers streamline their research and development processes. Link
SOME INTERESTING STARTUPS FOUND
Block Pharma (2016, Paris) – Company offering solutions to counter fakes in pharmaceutical supply chain using blockchain and cryptographic techniques.
Drug Dosing Predictions (2016, Lyon) – Offers online tool that uses an in-vivo static mechanistic model to predict the pharmacokinetic interactions mediated by P450 cytochromes with substrates and inhibitors/inducers, and evaluate the impact of polymorphism and cirrhosis data monitoring and source data verification for clinical trials.
Pharmaceutical Artificial Intelligence (2016, Bethesda) – It is developing a multi-modal input drug discovery engine using deep learning algorithms.
LEADER BOARD – LIFE SCIENCE – SOFTWARE
Leader Board – Life Sciences – Software
Bioinformatics
Metabolon (2000, Durham, $77.42M) provides platforms and informatics systems for biomarker discoveries and diagnostic tests and also offers metabolomics research services. Backed by Aurora Funds, Sevin Rosen Funds, Camden Partners Holdings, Essex Woodlands, HHVC, Sumitomo Corp, Syngenta, Alexandria Real Estate Equities, ATEL Capital Group, Fletcher Spaght, The Trelys Funds, Fulcrum Financial Group, and Crossroads Capital.
Simulations Plus (1996, Lancaster, Public) develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling & simulation software for cheminformatics and drug discovery and provides consulting services.
Inpharmatica (1998, Saffron Walden, $75M, Acq) offers predictive informatics solutions and services for medicinal chemistry and ADME to help improve the speed and productivity of drug discovery. It is also involved in research of drugs and biomarkers. Backed by Vertex Ventures, Advent Venture Partners, Gimv, Gilde, 3i Group, Abingworth, Unibio, and REV. Acquired by Galapagos in Dec 2006.
Schrodinger (1990, New York, $52M) develops software solutions for computational chemistry, research and drug discovery. Backed by Cascade Investment.
Imaging Solutions
Aperio Technologies (1999, California, $47.6M, Acq) offers digital pathology solutions including image management, sharing and analysis solutions. Backed by BlackRock, Advanced Technology Ventures, HLM Venture Partners, and Galen Partners. Acquired by Leica Microsystems in Aug 2012.
Parexel (1983, Massachusetts, Public) is a clinical research organization which offers clinical trial management solutions and services. Backed by Capvis.
inviCRO (2008, Boston, $45.8M) provides advanced data analysis services and software in the field of preclinical imaging research.
Media Technologies (2002, Valbonne, $53.66M, Public) offers medical imaging software and services for oncology clinical trials, cancer screening, and clinical practice. Backed by NEA, Draper Fisher Jurvetson, Auriga Partners, Abingworth, Omega Funds, Idinvest Partners, National Technology Enterprises Company, Kuwait Life Sciences Company (KLSC), and AGF Private Equity.
Clinical Trial Solutions
Medidata (1999, New York, $66.18 M, Public) provides cloud based solutions for clinical trial management and analytics. Backed by Insight Venture Partners, Milestone Venture Partners, Stonehenge Growth Equity, Silicon Alley Venture Partners, The Lambda Funds, State Street, and Alpha Venture Partners and went public in June, 2009.
Parexel (1983, Massachusetts, Public) is a clinical research organization which offers clinical trial management solutions and services. Backed by Capvis.
Datatrak International (1991, Cleveland, Public) offers clinical enterprise solutions which include tools for electronic data capture, trial design, trial supply management and project management.
Comprehend (2010, Palo Alto, $30.8M) provides clinical data reporting and visualization tools for clinical trials. Backed by Y Combinator, Lightspeed Venture Partners, Sequoia Capital, SV Angel, Menlo Ventures, Crosslink Capital, Quotidian Ventures, Ulu Ventures, Life Sciences Angel Network, and Easton Capital.
GRC Solutions
Metric Stream (1999, Palo Alto, $123M) provides solutions for quality management, regulatory compliance, risk management, and corporate governance. Backed by Goldman Sachs, KPCB, Integral Capital Partners, Gold Hill Capital, Sageview Capital, Saints Capital, Kaiser Permanente Ventures, Blade Ventures, Montage Capital, and The Camelot Group.
Virtify (2004, Lexington, $23.5M) provides enterprise content and compliance management solutions for the life sciences industry. Backed by Tudor Growth Equity, Blue Cloud Ventures, and Spring Lake Equity Partners.
Qumas (1994, Cork, $10M, Acq) provides Compliance and Quality Management Software for Life Sciences including solutions for document management, process management and submission management. Backed by General Catalyst Partners, Fidelity Ventures, Delta Partners, ACT Venture Capital, Fidelity Growth Partners Europe, Kernel Capital, and Eight Roads Ventures. Acquired by Accelrys in Dec, 2013.
Workflow Automation Solutions
Emerald Therapeutics (2010, San Francisco, $34M) has developed Emerald Cloud Laboratory that scientists can remotely access via the internet and can perform experiments using automated robotics. Backed by Founders Fund, Western Technology Investment, and Schooner Capital.
Quartzy (2009, Palo Alto, $28.8M) offers web-based platform for lab management and supports collaboration, inventory and order management. It also hosts catalogs from vendors for lab consumables. Backed by Y Combinator, Lerer Hippeau Ventures, SV Angel, Khosla Ventures, Washington U., Silicon Badia, Reinmkr Satsang, A Capital, Life Science Angels, Science House, Accelerator Tech, Lerer Hippeau Ventures, and Eminence Capital.
Market Intelligence
IMS Health (1954, Danbury, Public) offers a suite of market intelligence products and services which are aimed at improving productivity and healthcare delivery of healthcare organizations.
Zephyr Health (2011, San Francisco, $33.5 M) offers Zephyr Illuminate, an Insights-as-a-Service platform designed to help companies improve product life cycle performance with customer and market insights and can be used for collaboration, targeting and segmentation, and planning. Backed by KPCB, Jafco Ventures, and Icon Ventures.
Sales and Marketing
Veeva Systems (2007, San Francisco, $ 4 M, Public) offers Content Management, Customer Relationship Management, Customer Master data management and related software and services to the life sciences industry. Backed by Lead Edge Capital, and Emergence Capital. Went public in October 2013.
Aktana (2008, San Francisco, $25 M) offers sales force solutions and customer relationship management solutions for life sciences industry. Backed by Safeguard Scientifics, and Starfish Ventures.
Operations Management and Supply Chain
Tracelink (2009, Woburn, $25.5 M) offers an online platform for global distribution, visibility and traceability of pharmaceuticals to limit the sale of counterfeit drugs. Backed by FirstMark Capital, Volition Capital, and F-Prime Capital Partners.
Bluechiip (2003, Scoresby, Public) provides wireless tracking solutions for bio samples and other products. Went public in Oct, 2010 via a reverse takeover by Sofcom Limited.
Leaderboard includes all the top funded, IPO and successfully running bootstrapped companies along with their location, founding year and funding amount.
For latest updates, visit Life Sciences – Software feed.
